Avai Bio Inc (AVAI)

[resx18]

Avant's Chief Executive Officer, Chris Winter, said, "It is the work we're doing with Ainnova to screen diabetes patients to identify the early signs of diabetic retinopathy that is driving Avant to contribute even more to the fast-growing disease - a potential treatment. We are exploring several promising opportunities to get involved in the development of a treatment for diabetes globally, and if successful, we want to be ready to hit the ground running with the formation of a company to house that opportunity."